I think the manfuacturing costs are a small part of the supply chain in the US. Everyone is getting excited that prices achieved will be in the 5-700 range, but there is an awful lot of ancilary costs in the US medical drug market supply chain. I have no idea or experience what they are and I don't see them articulated in the presentations.
BOT - Anything but charting, page-8523
-
- There are more pages in this discussion • 844 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.020(5.41%) |
Mkt cap ! $642.5M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 34.3¢ | $1.645M | 4.671M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 234273 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 269361 | 11 |
View Market Depth
| Last trade - 13.22pm 22/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |